Back to Feed
总结
强生公司（Johnson & Johnson）近日宣布与美国政府达成协议，承诺通过降价与折扣等安排改善处方药可及性、降低数百万美国人的用药成本，并配合政府推动药价改革。作为交换，协议涉及对部分产品给予关税豁免，同时要求公司兑现在美国制造、供应链与创新研发方面的投资计划。该安排与特朗普政府推动的药企降价交易及“TrumpRx”处方药折扣计划相呼应，实际能为患者节省多少仍取决于后续细则披露与落地执行。
正文
Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments Johnson & Johnson J&J strikes deal with US government to cut drug prices, gain tariff exemptions Reuters Trump has announced deals with drugmakers to cut costs. Will they save people money? NBC News TrumpRx will launch soon. What we know about new prescription drug discounts The Clarion-Ledger Johnson & Johnson Reaches Deal With Trump Administration to Lower Drug Prices - WSJ The Wall Street Journal
发布时间：